Ellen S. Rafferty

Edmonton, AB, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Characteristics of outpatient nirmatrelvir/ritonavir recipients during the 2022/2023 era in Alberta, Canada: A retrospective observational population-based study.

Characteristics of outpatient nirmatrelvir/ritonavir recipients during the 2022/2023 era in Alberta, Canada: A retrospective observational population-based study.

Journal: Canada communicable disease report = Releve des maladies transmissibles au Canada

Published: August 20, 2026

Barriers and facilitators for return-to-work following post-COVID-19 condition: A scoping review.

Barriers and facilitators for return-to-work following post-COVID-19 condition: A scoping review.

Journal: Work (Reading, Mass.)

Published: June 03, 2026

Vaccination as cost-stabilizing health infrastructure: A Canadian perspective.

Vaccination as cost-stabilizing health infrastructure: A Canadian perspective.

Journal: Canadian journal of public health = Revue canadienne de sante publique

Published: February 20, 2026

Evaluating respiratory syncytial virus immunization strategies for infants in Canada: A cost-utility analysis.

Evaluating respiratory syncytial virus immunization strategies for infants in Canada: A cost-utility analysis.

Journal: PloS one

Published: January 12, 2026

Eligibility for Nirmatrelvir/Ritonavir Among Adults With an Acute Care COVID-19 Encounter: A Retrospective Cohort Study From Alberta, Canada.

Eligibility for Nirmatrelvir/Ritonavir Among Adults With an Acute Care COVID-19 Encounter: A Retrospective Cohort Study From Alberta, Canada.

Journal: Pharmacoepidemiology and drug safety

Published: June 27, 2025

The impact of testing positive versus negative for COVID-19 on health-related quality of life: cross-sectional evidence from the Alberta post-COVID-19 follow-up survey.

The impact of testing positive versus negative for COVID-19 on health-related quality of life: cross-sectional evidence from the Alberta post-COVID-19 follow-up survey.

Journal: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation

Published: May 12, 2025

A national curriculum and community of practice for health services and policy research training: Insights from the Health System Impact Fellowship National Cohort Training Program (HSIF NCTP).

A national curriculum and community of practice for health services and policy research training: Insights from the Health System Impact Fellowship National Cohort Training Program (HSIF NCTP).

Journal: Learning health systems

Published: April 06, 2025

The decision uncertainty toolkit: Risk measures and visual outputs to support decision making during public health crises.

The decision uncertainty toolkit: Risk measures and visual outputs to support decision making during public health crises.

Journal: PloS one

Published: January 02, 2025

Sex Differences in the Immunogenicity and Efficacy of Seasonal Influenza Vaccines: A Meta-analysis of Randomized Controlled Trials.

Sex Differences in the Immunogenicity and Efficacy of Seasonal Influenza Vaccines: A Meta-analysis of Randomized Controlled Trials.

Journal: Open forum infectious diseases

Published: March 28, 2024

Cost-effectiveness of RSVpreF vaccine and nirsevimab for the prevention of respiratory syncytial virus disease in Canadian infants.

Cost-effectiveness of RSVpreF vaccine and nirsevimab for the prevention of respiratory syncytial virus disease in Canadian infants.

Journal: Vaccine

Published: March 26, 2024

Healthcare costs and effects of post-COVID-19 condition in Canada.

Healthcare costs and effects of post-COVID-19 condition in Canada.

Journal: Canada communicable disease report = Releve des maladies transmissibles au Canada

Published: March 14, 2024

Quantifying the economic gains associated with COVID-19 vaccination in the Canadian population: A cost-benefit analysis.

Quantifying the economic gains associated with COVID-19 vaccination in the Canadian population: A cost-benefit analysis.

Journal: Canada communicable disease report = Releve des maladies transmissibles au Canada

Published: March 05, 2024

Showing 1-12 of 41

Last Updated: 09/26/2026